Evaluation of Dapagliflozin Taken Twice-daily

Clinical trial NCT01217892 · COMPLETED

Trial details

NCT number: NCT01217892
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2010-11-01
Primary completion: 2011-08-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.